Adamas Pharmaceuticals' Grant

Adamas Pharmaceuticals raised a round of funding on September 16, 2009. Investors include Qualifying Therapeutic Discovery Project.

Adamas, formerly NeuroMolecular Pharmaceuticals, is a pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including infl…

Articles about Adamas Pharmaceuticals' Grant: